Lilly's Omvoh® (Mirikizumab) Recommended by Chmp for Approval in the European Union for Adults With Moderately to Severely Active Crohn's Disease
礼来公司的Omvoh®(Mirikizumab)获得CHMP推荐,在欧盟批准用于中度至重度活动的克罗恩病成年患者。
Lilly's Omvoh® (Mirikizumab) Recommended by Chmp for Approval in the European Union for Adults With Moderately to Severely Active Crohn's Disease
礼来公司的Omvoh®(Mirikizumab)获得CHMP推荐,在欧盟批准用于中度至重度活动的克罗恩病成年患者。
使用浏览器的分享功能,分享给你的好友吧